Data / Form D filings / CorMedix Inc.
CorMedix Inc.: Form D filings
CorMedix Inc., a pharmaceuticals company in Bridgewater, NJ, filed 2 Form D notices with the SEC between 2009 and 2012. The latest, on October 3, 2012, reports $850,000 sold of a $3 million offering to 8 investors.
Find out what CorMedix Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 745 ROUTE 202-206, SUITE 303, Bridgewater, NJ, 08807
- Phone
- (908) 517-9500
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1410098
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 3, 2012 | New notice | $3,000,000 | $850,000 | $2,150,000 | 8 | Sep 11, 2012 | sec.gov |
| Nov 13, 2009 | New notice | $2,700,000 | $2,619,973 | $80,027 | 19 | Oct 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony E. Pfaffle | Director | |
| Matthew W. Duffy | Director | |
| Steven W. Lefkowitz | Director | |
| Richard M. Cohen | Executive Officer, Director | |
| Timothy A. Hofer | Director | |
| Gary A. Gelbfish | Director | |
| Randy W. Milby | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Oct 1, 2012 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CorMedix Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.